XML 16 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:    
Net income $ 230,377 $ 95,651
Adjustment to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 66,453 58,945
Stock-based compensation costs 25,011 23,958
Loss attributable to equity method investments (note 6) 3,375
Impairment of equity investments (note 6) 2,959 2,254
Changes in fair value of business combination contingent consideration (note 12) (272)  
Changes in operating assets and liabilities, net of effect of acquisitions:    
Accounts receivable 32,366 (26,145)
Inventories (30,570) (20,760)
Prepaid expenses, net deferred income taxes and other current assets (26,922) (2,858)
Accounts payable, accrued expenses and other (125,190) 95,489
Net cash provided by operating activities 177,587 226,534
Cash flows from investing activities:    
Purchases of property, plant and equipment (31,425) (32,000)
Patent registration costs (4,643) (4,624)
Business acquisitions, net of cash acquired (739,249)  
Purchases of investments (note 6) (27,967) (3,725)
Proceeds (payments) on maturity of foreign currency contracts (3,127) (3,330)
Net cash used in investing activities (806,411) (43,679)
Cash flows from financing activities:    
Proceeds from issuance of common stock, net 12,784 20,440
Taxes paid related to net share settlement of equity awards (27,340) (13,853)
Purchases of treasury stock (22,844) (8,541)
Payments of business combination contingent consideration (note 12) (430)  
Proceeds from borrowings, net of borrowing costs 1,091,230 50,000
Repayment of borrowings (352,798) (110,000)
Dividend paid (105,567) (99,553)
Net cash provided by (used in) financing activities 595,035 (161,507)
Effect of exchange rate changes on cash (5,444) 15,616
Net increaase (decrease) in cash and cash equivalents (39,233) 36,964
Cash and cash equivalents at beginning of period 188,701 821,935
Cash and cash equivalents at end of period 149,468 858,899
Supplemental disclosure of cash flow information:    
Income taxes paid, net of refunds 192,497 51,456
Interest paid 11,195 $ 15,155
Fair value of assets acquired, excluding cash 343,470  
Liabilities assumed (298,554)  
Goodwill on acquisition 695,353  
Deferred payments (852)  
Fair value of contingent consideration (168)  
Cash paid for acquisition $ 739,249